US21871N1019 - Common Stock

**CXW** gets a fundamental rating of **3** out of 10. The analysis compared the fundamentals against 84 industry peers in the **Commercial Services & Supplies** industry. While **CXW** is still in line with the averages on profitability rating, there are concerns on its financial health. **CXW** is not valued too expensively and it also shows a decent growth rate.

In the past year **CXW** was profitable.

In the past year **CXW** had a positive cash flow from operations.

Of the past 5 years **CXW** 4 years were profitable.

Each year in the past 5 years **CXW** had a positive operating cash flow.

Looking at the **Return On Equity**, with a value of **4.48%**, **CXW** is in line with its industry, outperforming **56.63%** of the companies in the same industry.

The **Return On Invested Capital** of **CXW** (**5.03%**) is comparable to the rest of the industry.

The 3 year average ROIC (**4.93%**) for **CXW** is below the current ROIC(**5.03%**), indicating increased profibility in the last year.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 2.14% | ||

ROE | 4.48% | ||

ROIC | 5.03% |

ROA(3y)1.49%

ROA(5y)2.18%

ROE(3y)3.11%

ROE(5y)5.39%

ROIC(3y)4.93%

ROIC(5y)5.12%

With a decent **Profit Margin** value of **3.34%**, **CXW** is doing good in the industry, outperforming **65.06%** of the companies in the same industry.

With a decent **Operating Margin** value of **9.56%**, **CXW** is doing good in the industry, outperforming **69.88%** of the companies in the same industry.

In the last couple of years the **Gross Margin** of **CXW** has declined.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 9.56% | ||

PM (TTM) | 3.34% | ||

GM | 23.38% |

OM growth 3Y-8.49%

OM growth 5Y-8.46%

PM growth 3Y7.8%

PM growth 5Y-16.29%

GM growth 3Y-4.39%

GM growth 5Y-4.19%

The number of shares outstanding for **CXW** has been reduced compared to 5 years ago.

With a **Debt to FCF ratio** value of **7.86**, **CXW** perfoms like the industry average, outperforming **54.22%** of the companies in the same industry.

A Debt/Equity ratio of **0.68** indicates that **CXW** is somewhat dependend on debt financing.

The **Debt to Equity ratio** of **CXW** (**0.68**) is comparable to the rest of the industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.68 | ||

Debt/FCF | 7.86 | ||

Altman-Z | 1.37 |

ROIC/WACC0.56

WACC8.96%

A Quick Ratio of **1.17** indicates that **CXW** should not have too much problems paying its short term obligations.

The **Quick ratio** of **CXW** (**1.17**) is comparable to the rest of the industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.17 | ||

Quick Ratio | 1.17 |

The earnings per share for **CXW** have decreased strongly by **-43.43%** in the last year.

EPS 1Y (TTM)-43.43%

EPS 3Y6.39%

EPS 5Y-15.75%

EPS Q2Q%-27.27%

Revenue 1Y (TTM)4.81%

Revenue growth 3Y-0.16%

Revenue growth 5Y0.65%

Sales Q2Q%9.32%

The **Earnings Per Share** is expected to grow by **25.04%** on average over the next years. This is a very strong growth

Based on estimates for the next years, **CXW** will show a small growth in **Revenue**. The Revenue will grow by **3.21%** on average per year.

EPS Next Y-5.85%

EPS Next 2Y25.04%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year4.39%

Revenue Next 2Y3.21%

Revenue Next 3YN/A

Revenue Next 5YN/A

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

Based on the **Price/Earnings** ratio of **26.89**, the valuation of **CXW** can be described as expensive.

The average S&P500 **Price/Earnings** ratio is at **28.20**. **CXW** is around the same levels.

A **Price/Forward Earnings** ratio of **16.33** indicates a correct valuation of **CXW**.

Based on the **Price/Forward Earnings** ratio, **CXW** is valued a bit cheaper than 68.67% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 26.89 | ||

Fwd PE | 16.33 |

Based on the **Enterprise Value to EBITDA** ratio, **CXW** is valued a bit cheaper than 77.11% of the companies in the same industry.

Based on the **Price/Free Cash Flow** ratio, **CXW** is valued a bit cheaper than 75.90% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 12.03 | ||

EV/EBITDA | 8.52 |

A more expensive valuation may be justified as **CXW**'s earnings are expected to grow with **25.04%** in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y25.04%

EPS Next 3YN/A

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

**CORECIVIC INC**

NYSE:CXW (5/29/2024, 3:15:00 PM)

After market: 15.06 0 (0%)**15.06**

**-0.11 (-0.73%) **

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCommercial & Professional Services

GICS IndustryCommercial Services & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap1.68B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 26.89 | ||

Fwd PE | 16.33 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 2.14% | ||

ROE | 4.48% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 9.56% | ||

PM (TTM) | 3.34% | ||

GM | 23.38% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.64

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.68 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.17 | ||

Quick Ratio | 1.17 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)-43.43%

EPS 3Y6.39%

EPS 5Y

EPS Q2Q%

EPS Next Y-5.85%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)4.81%

Revenue growth 3Y-0.16%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y